WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

NHSA Issues Notice to Enhance Drug Pricing and Procurement Credit Evaluation S... China's NHSA released a notification titled "Notice on Further Improving the Drug Pricing and Procurement Credit Evaluation System." This directive aims to strengthen ove...
(6/5/2025)

China Emerges as Prime Global Target for Multi... (6/17/2025)

China Proposes Shorter Clinical Trial Reviews ... (6/16/2025)

China's AI Healthcare Market (Part II): Opport... (6/12/2025)

China's AI Healthcare Market (Part I): Growth ... (6/12/2025)

Following FDA's Elsa, China Accelerates AI Hea... (6/9/2025)

China Ascends to Global Leadership in Oncology... (6/5/2025)

Mainland Chinese Market for Weight Loss and Di... (6/5/2025)

Driving Business Growth Through Investment Fun... (6/4/2025)

2025 Outlook for Medtech in China (Simon Kuche... (6/2/2025)

China's Clinical Trial Boom (Asimov Press) (5/22/2025)

'China's Ozempic' may vie with Eli Lilly, Novo... (5/20/2025)

How Trump's Proposed Price Cuts Could Hurt Chi... (5/20/2025)

GenMedicn Secures Series B Funding to F... (6/18/2025) FDA Clears Boan Biotech to Advance Innov... (6/18/2025) EpimAb's HKEX IPO Application Accepted, ... (6/18/2025) Abbisko Launches Pivotal Irpagratinib Tr... (6/18/2025) NMPA Holds Meeting to Review QMS in Vacc... (6/17/2025) Merck's Long-Acting RSV Antibody Clesrov... (6/17/2025) BioTroy Thera Secures Over CNY 200M in... (6/17/2025) Xiaolu Biomedicine Secures Tens of Mlns... (6/17/2025) SunRock Biopharma and Escugen Forge Alli... (6/17/2025) Lupin Partners with Sino Universal Pharm... (6/16/2025) NMPA Seeks Comments on Initiative to Opt... (6/16/2025) Teva, Fosun Pharma Partner to Develop Im... (6/16/2025) Merck's Keytruda Gains NMPA Approval in ... (6/16/2025) Xuanzhu Prepares for HKSE Main Board Lis... (6/16/2025) Legend Reportedly Disbands China Sales &... (6/16/2025) CARsgen Delivers Deep Responses with CT0... (6/16/2025) Hengrui Presents Positive Phase 2 Obesi... (6/16/2025) NextCure and Simcere Zaiming Announce St... (6/16/2025)

NH's DB6: China's Consumer Healthcare Market Underperfo... China's Hospital Drug Market Shows Slight Growth in 202... China Unveils Ambitious Plan to Boost Health-Related Co... Chinese VMS OTC Market Growth Slowed to 2.7% in 2024 Newish Tech Secures Series B Financing to Advance Next-...

EpimAb's HKEX IPO Application Accepted, Prospectus Now ... GenMedicn Secures Series B Funding to Fuel Gene Therap... SunRock Biopharma and Escugen Forge Alliance to Develop... Xiaolu Biomedicine Secures Tens of Mlns in Angel Fundi... BioTroy Thera Secures Over CNY 200M in Series A Finan...

NMPA Seeks Comments on Initiative to Optimize Clinical ... CDE Seeks Public Feedback on Second Batch of 2025 Exter... CDE Seeks Comments on Draft Guidelines for Defining and... CDE Solicits Comments on Draft Guidance on Post-Approva... NMPA Reopens Comment on Draft Announcement for Strength...

China Issues 2025 Action Plan to Combat Malpractice in... NHSA Issues Notice to Enhance Drug Pricing and Procurem... China's Child Health Improves: NHC Official China Expands Geriatric Services at Major Hospitals as ... China's BMI Fund Reports Big Surplus in Q1/2025

Tianjin Slaps CNY 362M Fine for Drug Price-Fixing Sche... Gavi Launches $224M Arbitration Claim Against Clover Bi... AstraZeneca Faces Escalating Legal Challenges in China ... BeiGene Secures Key Patent Victory in Brukinsa Dispute ... State Council Approves Draft Medical Security Law, Stre...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

Abbisko Launches Pivotal Irpagratinib Trial Targeting F... FDA Clears Boan Biotech to Advance Innovative CD228‑Ta... Merck's Long-Acting RSV Antibody Clesrovimab Recommende... Hengrui Presents Positive Phase 2 Obesity Data at ADA... CARsgen Delivers Deep Responses with CT071 in Newly Dia...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Former CFDA Commissioner Bi Jingquan Under Investigati... Recent Official and Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...